Ondine Biomedical Inc Net Asset Quality Index

Latest as of June 2026: -36.0%

Ondine Biomedical Inc net asset quality index. Ondine Biomedical Inc (OBI) has a Net Asset Quality Index of -36.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX8.95 Million minus total liabilities of GBX12.17 Million yields net assets of GBX-3.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. See OBI book value for net asset value and shareholders' equity analysis.

Quality Index

-36.0%
Equity / Total Assets

Net Assets

GBX-3.22 Million
GBX

Total Assets

GBX8.95 Million
GBX

Total Liabilities

GBX12.17 Million
GBX

Net Asset Quality Index of Ondine Biomedical Inc (2001–2025)

Net asset quality index of Ondine Biomedical Inc from 2001 to 2025. This chart shows how Ondine Biomedical Inc's Net Asset Quality Index has evolved across 18 annual periods from 2001 to 2025. As of June 2026, the index stands at -36.0%, representing net assets of GBX-3.22 Million against total assets of GBX8.95 Million GBX. Check Ondine Biomedical Inc (OBI) strategic investment index to assess the company's strategic physical and investment asset allocation.

Ondine Biomedical Inc Net Asset Quality Index by Year (2001–2025)

Ondine Biomedical Inc net asset quality index by year from 2001 to 2025. The table below presents the year-by-year Net Asset Quality Index for Ondine Biomedical Inc from 2001 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Ondine Biomedical Inc (OBI) total market value.

Year Quality Index Net Assets (GBX) Total Assets Total Liabilities Change (pp)
2025 24.2% GBX3.49 Million GBX14.40 Million GBX10.91 Million ▼ -29.4 pp
2024 53.6% GBX6.88 Million GBX12.82 Million GBX5.95 Million ▲ +17.3 pp
2023 36.4% GBX2.08 Million GBX5.73 Million GBX3.65 Million ▼ -33.9 pp
2022 70.3% GBX11.64 Million GBX16.57 Million GBX4.92 Million ▼ -16.6 pp
2021 86.9% GBX29.66 Million GBX34.14 Million GBX4.48 Million ▲ +1370.7 pp
2020 -1283.8% GBX-33.83 Million GBX2.63 Million GBX36.46 Million ▼ -388.7 pp
2019 -895.1% GBX-26.07 Million GBX2.91 Million GBX28.99 Million ▼ -497.1 pp
2018 -397.9% GBX-17.90 Million GBX4.50 Million GBX22.40 Million ▼ -281.1 pp
2017 -116.8% GBX-6.55 Million GBX5.61 Million GBX12.16 Million ▼ -127.8 pp
2010 11.0% GBX279.19K GBX2.53 Million GBX2.25 Million ▼ -37.8 pp
2009 48.8% GBX1.28 Million GBX2.62 Million GBX1.34 Million ▲ +3.4 pp
2008 45.4% GBX1.34 Million GBX2.95 Million GBX1.61 Million ▼ -38.0 pp
2007 83.4% GBX10.84 Million GBX13.00 Million GBX2.16 Million ▼ -6.5 pp
2006 89.9% GBX16.59 Million GBX18.46 Million GBX1.87 Million ▼ -5.8 pp
2005 95.7% GBX16.50 Million GBX17.25 Million GBX745.61K ▲ +3672.4 pp
2003 -3576.7% GBX-227.62K GBX6.36K GBX233.99K ▲ +13319.5 pp
2002 -16896.2% GBX-143.28K GBX848.00 GBX144.13K ▼ -16992.2 pp
2001 96.0% GBX1.39 Million GBX1.45 Million GBX58.02K —
pp = percentage points